INGELVAC MYCOFLEX SUSPENSION FOR INJECTION FOR PIGS

Nchi: Ayalandi

Lugha: Kiingereza

Chanzo: HPRA (Health Products Regulatory Authority)

Nunua Sasa

Tabia za bidhaa Tabia za bidhaa (SPC)
25-02-2016

Viambatanisho vya kazi:

INACTIVATED MYCOPLASMA HYOPNEUMONIAE, J STRAIN ISOLATE B-3745

Inapatikana kutoka:

Boehringer Ingelheim Ltd

ATC kanuni:

QI09AB13

INN (Jina la Kimataifa):

INACTIVATED MYCOPLASMA HYOPNEUMONIAE, J STRAIN ISOLATE B-3745

Kipimo:

Unknown

Dawa fomu:

Suspension for Injection

Dawa ya aina:

LM-Licensed Merchant

Kundi la matibabu:

Porcine

Eneo la matibabu:

Mycoplasma vaccine

Matibabu dalili:

Immunological - Inactivated vaccine

Idhini hali ya:

Authorised

Idhini ya tarehe:

2009-07-24

Tabia za bidhaa

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Ingelvac MycoFLEX suspension for injection for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Inactivated _Mycoplasma hyopneumoniae_, J Strain Isolate B-3745.
Each dose (1 ml) of inactivated vaccine contains:
ACTIVE SUBSTANCE:
_Mycoplasma hyopneumoniae_: > 1 RP*
*Relative potency (ELISA test) by comparison with a reference vaccine.
ADJUVANT:
Carbomer:
1 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection.
Clear to slightly opalescent, pink to brown suspension for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (fattening pigs or future breeders until first reproductive service).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of pigs from 3 weeks of age to reduce lung lesions following infection with _Mycoplasma_
_hyopneumoniae_.
Onset of protection occurs by 2 weeks post vaccination and lasts for at least 26 weeks.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 10/02/2016_
_CRN 7022210_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Vaccinate healthy animals only.
In case of anaphylactic-type reactions, the administration of epinephrine is recommended.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Not applicable.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Adverse reactions are very rare (less than 1 animal in 10,000 animals, including isolated reports):
-
anaphylactic-type reactions may occur and should be treated symptomatically (e.g. epinephrine)
-
tra
                                
                                Soma hati kamili